Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	6,154	16,169	18,626	20,592	12,613	9,828
Market Cap Growth	-54.84%	-13.19%	-9.54%	63.27%	28.33%	26.51%
Enterprise Value	31,228	39,765	42,351	40,514	28,904	23,780
Last Close Price	26.30	67.36	76.63	83.74	50.68	38.57
PE Ratio	-	50.83	29.06	24.34	13.43	14.76
PS Ratio	0.99	1.52	1.34	2.13	1.16	1.29
PB Ratio	0.28	0.70	0.83	0.99	0.63	0.51
P/TBV Ratio	0.29	0.75	0.89	1.07	0.68	0.55
P/FCF Ratio	125.00	-	-	-	-	29.00
P/OCF Ratio	2.94	10.19	7.47	17.73	4.87	5.22
EV/Sales Ratio	5.04	3.74	3.04	4.19	2.67	3.11
EV/EBITDA Ratio	25.77	26.51	26.91	35.29	11.43	9.66
EV/EBIT Ratio	54.71	42.80	42.65	60.01	18.79	15.32
EV/FCF Ratio	634.27	-	-	-	-	70.17
Debt / Equity Ratio	1.06	0.98	0.98	0.90	0.84	0.72
Debt / EBITDA Ratio	19.73	14.83	13.74	15.87	6.59	5.51
Debt / FCF Ratio	482.00	-	-	-	-	40.50
Asset Turnover	0.12	0.20	0.28	0.21	0.27	0.23
Inventory Turnover	2.62	5.04	7.12	5.01	6.10	4.62
Quick Ratio	1.69	1.82	1.64	1.59	2.14	2.86
Current Ratio	1.99	2.17	2.01	1.99	2.70	3.99
Return on Equity (ROE)	-0.63%	1.55%	3.22%	4.36%	5.73%	3.89%
Return on Assets (ROA)	0.66%	1.09%	1.23%	0.93%	2.43%	2.86%
Return on Capital (ROIC)	0.77%	1.29%	1.48%	1.11%	2.75%	3.21%
Return on Capital Employed (ROCE)	1.20%	2.00%	2.30%	1.70%	4.20%	4.80%
Earnings Yield	-1.78%	1.97%	3.44%	4.11%	7.45%	6.77%
FCF Yield	0.80%	-1.79%	-7.33%	-7.31%	-13.36%	3.45%
Dividend Yield	3.80%	1.48%	1.31%	1.19%	2.37%	2.59%
Payout Ratio	-	84.84%	23.86%	38.36%	36.22%	56.04%
Total Shareholder Return	3.80%	1.48%	1.31%	1.19%	2.37%	2.59%

Updated Feb 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.